HDFC Pharma and Healthcare Fund vs Nippon India Pharma Fund compare
HDFC Pharma and Healthcare Fund - Regular (G)
Nippon India Pharma Fund-Growth Plan-Growth Option
Chart Comparison
Overview
| Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | Nippon India Pharma Fund-Growth Plan-Growth Option |
|---|---|---|
| Fund | HDFC Pharma and Healthcare Fund - Regular (G) | Nippon India Pharma Fund-Growth Plan-Growth Option |
| Investment Plan | Growth | Growth |
| Level of Risk | Very High | Very High |
| Asset Size (Cr) | ₹1984 Cr | ₹8265 Cr |
| Min Investment | ₹100 | ₹5000 |
| Min SIP Invesment | ₹100 | ₹500 |
| Min Addl Investment | ₹100 | ₹1000 |
| Launch Date | 04 Oct 2023 | 05 Jun 2004 |
| Category | Pharma & Healthcare | Pharma & Healthcare |
| Fund Type | Open Ended | Open Ended |
| Benchmark | BSE Healthcare Index | BSE Healthcare |
| Turn Over | % | 21% |
| Expense Ratio | 2.14 | 1.82 |
| Manager | Dhruv Muchhal | Sailesh Raj Bhan |
| ISIN Code | INF179KC1HL7 | INF204K01968 |
| Exits Load | HDFC Pharma and Healthcare Fund - Regular Plan - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 | Nippon India Pharma Fund - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 |
Trailing Lumpsum Returns
| Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | Nippon India Pharma Fund-Growth Plan-Growth Option |
|---|---|---|
| 1 Month | -4.33% | -4.85% |
| 6 Month | -8.23% | -10.03% |
| 1 Year | 4.51% | 1.58% |
| 3 Year | - | 20.15% |
| 5 Year | - | 14.6% |
SIP Return Analysis
| Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | Nippon India Pharma Fund-Growth Plan-Growth Option |
|---|---|---|
| 6 Month | -5.31% | -5.53% |
| 1 Year | -3.81% | -7.63% |
| 3 Year | - | 10.96% |
| 5 Year | - | 13.58% |
Rolling Lumpsum Returns
| Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | Nippon India Pharma Fund-Growth Plan-Growth Option |
|---|---|---|
| 1 Year | 26.12% | 16.54% |
| 3 Year | - | 21% |
| 5 Year | - | 20.33% |
Risk Management
| Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | Nippon India Pharma Fund-Growth Plan-Growth Option |
|---|---|---|
| Standard Deviation | - | 14.36% |
| Sharp | - | 1.01% |
| Beta | - | 0.87% |
| Alpha | - | 1.33% |
Fund Managers
| Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | Nippon India Pharma Fund-Growth Plan-Growth Option |
|---|---|---|
| Name | Dhruv Muchhal | Sailesh Raj Bhan |
| Total AUM | ₹520687 Cr | ₹96086 Cr |
| Funds Managed | 40 | 5 |
| HDFC Pharma and Healthcare Fund - Regular (G) | Nippon India Pharma Fund-Growth Plan-Growth Option |
Market Cap
| Scheme Name |
HDFC Pharma and Healthcare Fund - Regular (G) |
Nippon India Pharma Fund-Growth Plan-Growth Option |
|---|---|---|
| Others | 12.13 | 3.47 |
| Mid Cap | 31.4 | 34.55 |
| Small Cap | 30.56 | 29.97 |
| Large Cap | 25.91 | 32.01 |
Sector Allocation
| Scheme Name |
HDFC Pharma and Healthcare Fund - Regular (G) |
Nippon India Pharma Fund-Growth Plan-Growth Option |
|---|---|---|
| Others | 2.21 | 2.63 |
| Basic Materials | 2.91 | - |
| Healthcare | 94.88 | 97.37 |
Top Comparisons
SBI Small Cap Fund Regular Growth
3Y Returns12.52%
LIC MF Small Cap Fund Regular - Growth
3Y Returns16.05%
HSBC Liquid Fund - Regular Growth
3Y Returns6.92%
Axis Liquid Fund - Regular Plan - Growth Option
3Y Returns6.96%
HDFC Money Market Fund - Growth Option
3Y Returns7.34%
Edelweiss Money Market Fund - Regular Plan - Growth Option
3Y Returns6.67%
Invesco India Largecap Fund - Growth
3Y Returns18.18%
Edelweiss Large Cap Fund - Regular Plan - Growth Option
3Y Returns15.61%